Literature DB >> 3959697

Hearing aids poststapedectomy: incidence and timing.

G D Smyth, T H Hassard.   

Abstract

Ninety-four percent of 508 patients operated on between 1960 and 1975 have been followed-up at yearly intervals. Their status as of 1977 was assessed in order to determine their mean duration of socially adequate hearing levels and to relate the type of surgical procedure to the interval between operation and hearing aid requirement. Postoperative hearing losses due to conduction and sensorineural deficits resulted in preoperative bone/postoperative air gaps greater than 10 dB in up to 40% of large fenestra operations and in 15% of small fenestra operations at 5 years. On average, a large fenestra ear would require amplification at 13 years and a small fenestra ear at 21 years postoperatively.

Entities:  

Mesh:

Year:  1986        PMID: 3959697     DOI: 10.1288/00005537-198604000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Long-term results of the use of autogenous cortical bone columellas to replace the stapes at stapedectomy.

Authors:  Miklós Bauer; József Pytel; Ida Vóna; Imre Gerlinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-04       Impact factor: 2.503

2.  Hearing Aid Treatment in Patients with Mixed Hearing Loss. Part I: Expected Benefit and Limitations after Stapes Surgery.

Authors:  Nina Wardenga; Victoria Diedrich; Bernd Waldmann; Thomas Lenarz; Hannes Maier
Journal:  Audiol Neurootol       Date:  2020-02-11       Impact factor: 1.854

3.  Treatment of moderate-to-severe otosclerosis with simultaneous piston surgery and incus vibroplasty.

Authors:  Chan-Jung Chang; Yu-Hsuan Wen; Chuan-Hung Sun; Millo Achille Beltrame; Hung-Pin Wu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Apr-Jun

4.  Long term outcome of otosclerosis surgery.

Authors:  Maria Teresa Bernardo; Joana Dias; Daniela Ribeiro; Diamantino Helena; Artur Condé
Journal:  Braz J Otorhinolaryngol       Date:  2012 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.